News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amakem NV Appoints Jean Marie Stassen as Vice President, Research and Development


9/3/2013 6:31:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DIEPENBEEK, Belgium, September 3, 2013 /PRNewswire/ --

Amakem NV, a clinical stage ophthalmology company, today announces that Dr. Jean Marie Stassen has been appointed as Vice President, Research and Development.

Most recently Dr. Stassen was Head of Research & Development at Thrombogenics NV where he played a pivotal role in the successful development of ThromboGenics' lead product, ocriplasmin(JETREA®), from early pre-clinical through to regulatory submission. He joined ThromboGenics in 2001 and remained with the Company until retiring in 2012.

Help employers find you! Check out all the jobs and post your resume.

Read at PR Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES